JanOne Inc. (JAN)

4.1400 -0.1600 (-3.72%) At close: 04:00PM EDT

JanOne Inc.

325 East Warm Springs Road
Suite 102
Las Vegas, NV 89119
United States
702 997 5968
https://www.janone.com

Sector(s): Industrials
Industry: Waste Management
Full Time Employees: 5

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Tony Isaac	President, CEO, Corporate Secretary, Treasurer & Director	617.71k	N/A	1954
Mr. Virland A. Johnson CPA	Chief Financial Officer	224.35k	N/A	1963
Dr. Tony Giordano Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Dr. Douglas Flanagan	Chief Formulation Advisor	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. Its lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.

Corporate Governance

JanOne Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.